{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:55:03Z","timestamp":1792799703746,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychosomatic Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jpsychores.2020.110153","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T11:17:51Z","timestamp":1590232671000},"page":"110153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Association between opioid analgesic plus benzodiazepine use and death: A case-crossover study"],"prefix":"10.1016","volume":"135","author":[{"given":"Bo Ram","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Sun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha-Lim","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10028","key":"10.1016\/j.jpsychores.2020.110153_bb0005","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","article-title":"Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study","volume":"387","author":"Berterame","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.jpsychores.2020.110153_bb0010","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/pds.4278","article-title":"National trends in long-term use of prescription opioids","volume":"27","author":"Mojtabai","year":"2018","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"4","key":"10.1016\/j.jpsychores.2020.110153_bb0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/15360288.2016.1241336","article-title":"Prescription Opioid Cough Products, and Benzodiazepine Labeling Related to Serious Risks and Death From Combined Use","volume":"30","author":"Food, U.S.D.o.H. Drug Administration, S. Human, Food and Drug Administration Requires Strong Warnings for Opioid Analgesics","year":"2016","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"50\u201351","key":"10.1016\/j.jpsychores.2020.110153_bb0020","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths--United States, 2000-2014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.110153_bb0025","article-title":"Prescribed benzodiazepines and suicide risk: a review of the literature","volume":"19","author":"Dodds","year":"2017","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0030","first-page":"g1996","article-title":"Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study","volume":"348","author":"Weich","year":"2014","journal-title":"BMJ (Clinical research ed.)"},{"issue":"4","key":"10.1016\/j.jpsychores.2020.110153_bb0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00213-013-3127-4","article-title":"Benzodiazepine therapy in psychiatric outpatients is associated with deliberate self-poisoning events at emergency departments-a population-based nested case-control study","volume":"229","author":"Shih","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0040","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jpsychores.2020.110153_bb0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in outpatient benzodiazepine prescribing in the United States","volume":"2","author":"Agarwal","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.jpsychores.2020.110153_bb0050","first-page":"85","article-title":"Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Medicine (Malden, Mass.)"},{"issue":"3","key":"10.1016\/j.jpsychores.2020.110153_bb0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/j.pain.0000000000001111","article-title":"The relationship between concomitant benzodiazepine-opioid use and adverse outcomes among U.S. veterans","volume":"159","author":"Gressler","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0060","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"Bmj"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0065","doi-asserted-by":"crossref","first-page":"g445","DOI":"10.1136\/bmj.g445","article-title":"Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study","volume":"348","author":"Ekstrom","year":"2014","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.jpsychores.2020.110153_bb0070","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cpt.1376","article-title":"A case-crossover-based screening approach to identifying clinically relevant drug-drug interactions in electronic healthcare data","volume":"106","author":"Bykov","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.110153_bb0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/EDE.0000000000000944","article-title":"The case-crossover Design for Drug-Drug Interactions: considerations for implementation","volume":"30","author":"Bykov","year":"2019","journal-title":"Epidemiology"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0080","author":"Burke"},{"issue":"2","key":"10.1016\/j.jpsychores.2020.110153_bb0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a115853","article-title":"The case-crossover design: a method for studying transient effects on the risk of acute events","volume":"133","author":"Maclure","year":"1991","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.110153_bb0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40263-013-0038-1","article-title":"Newly initiated opioid treatment and the risk of fall-related injuries. A nationwide, register-based, case-crossover study in Sweden","volume":"27","author":"Soderberg","year":"2013","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.jpsychores.2020.110153_bb0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/pds.1333","article-title":"Changes in medication associated with epilepsy-related hospitalisation: a case-crossover study","volume":"16","author":"Handoko","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.110153_bb0100","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001568","article-title":"Antipsychotic drugs and the risk of ventricular arrhythmia and\/or sudden cardiac death: a nation-wide case-crossover study","volume":"4","author":"Wu","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.jpsychores.2020.110153_bb0105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00127-018-1637-4","article-title":"The association between antidepressant use and deaths from road traffic accidents: a case-crossover study","volume":"54","author":"Yang","year":"2019","journal-title":"Soc Psych Psych Epid"},{"issue":"2","key":"10.1016\/j.jpsychores.2020.110153_bb0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archinternmed.2008.525","article-title":"Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure","volume":"169","author":"Gislason","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.jpsychores.2020.110153_bb0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/pds.1932","article-title":"Antiepileptic drugs and risk of suicide: a nationwide study","volume":"19","author":"Olesen","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"6","key":"10.1016\/j.jpsychores.2020.110153_bb0120","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40263-018-0520-x","article-title":"Prescription of Zolpidem and the risk of fatal motor vehicle collisions: a population-based, Case-Crossover Study from South Korea","volume":"32","author":"Yang","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0125","series-title":"All of statistics: a concise course in statistical inference","author":"Wasserman","year":"2013"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0130","unstructured":"L.C. Brunton, Knollman, B., Goodman and Gilman's the Pharmacological Basis of Therapeutics, 13 ed., McGraw-Hill Education, United States of America."},{"key":"10.1016\/j.jpsychores.2020.110153_bb0135","series-title":"Opioid Morphine Equivalent Conversion Factors","author":"Centers for Medicare & Medicaid Services (CMC)","year":"2015"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0140","series-title":"Opioid Oral Morphine Milligram Equivalent (MME) Conversion Factors","author":"Centers for Medicare & Medicaid Services (CMC)","year":"2017"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0145","unstructured":"CVS caremark, Opioid IR Drug Class Federal Employee Program (FEP) Clinical Criteria."},{"key":"10.1016\/j.jpsychores.2020.110153_bb0150","unstructured":"Faculty of pain medicine-The Australian and New Zealand College of Anaesthetists (ANZCA), Opioid dose equivalence, 2019."},{"key":"10.1016\/j.jpsychores.2020.110153_bb0155","unstructured":"Gloicestershire Hospitals National Health Service Foundation Trust, Opioid Equivalence Chart."},{"key":"10.1016\/j.jpsychores.2020.110153_bb0160","series-title":"Sedation","author":"Malamed","year":"2010"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0165","series-title":"Opioid Equivalence Chart","author":"National Health Service (NHS)","year":"2011"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0170","series-title":"Martindale: The Complete Drug Reference","author":"Sweetman","year":"2009"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0175","unstructured":"The National Alliance of Advocates for Buprenorphine Treatment, Buprenex (buprenorphine hydrochloride) injection, solution."},{"key":"10.1016\/j.jpsychores.2020.110153_bb0180","author":"ClinCalc.com"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0185","series-title":"Lorazepam [package insert]","author":"DailyMed Monograph","year":"2010"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0190","unstructured":"Government of South Australia, Benzodiazepine equivalents."},{"issue":"8","key":"10.1016\/j.jpsychores.2020.110153_bb0195","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychores.2020.110153_bb0200","first-page":"319","article-title":"Comparison of mexazolam and diazepam in the treatment of neurosis: a double-blind controlled study","volume":"9","author":"Ito","year":"1981","journal-title":"Clin Eval"},{"issue":"3","key":"10.1016\/j.jpsychores.2020.110153_bb0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/j.1552-4604.1989.tb03327.x","article-title":"Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects","volume":"29","author":"Pentik\u00e4inen","year":"1989","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychores.2020.110153_bb0210","unstructured":"World Heritage Encyclopedia, Benzodiazepine equivalence, World Heritage Encyclopedia."},{"key":"10.1016\/j.jpsychores.2020.110153_bb0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","article-title":"Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study","volume":"174","author":"Abrahamsson","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.110153_bb0220","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare part D beneficiaries","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw. Open"},{"issue":"1\u20132","key":"10.1016\/j.jpsychores.2020.110153_bb0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.jpsychores.2020.110153_bb0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0897190013515001","article-title":"Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics","volume":"27","author":"Jann","year":"2014","journal-title":"J. Pharm. Pract."},{"issue":"4","key":"10.1016\/j.jpsychores.2020.110153_bb0235","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF02244235","article-title":"Chronic morphine administration augments benzodiazepine binding and GABAA receptor function","volume":"101","author":"Lopez","year":"1990","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.jpsychores.2020.110153_bb0240","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0361-9230(01)00785-7","article-title":"The interaction of morphine and gamma-aminobutyric acid (GABA)ergic systems in anxiolytic behavior: using mu-opioid receptor knockout mice","volume":"57","author":"Sasaki","year":"2002","journal-title":"Brain Res. Bull."},{"issue":"5","key":"10.1016\/j.jpsychores.2020.110153_bb0245","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0090-9556(24)12022-3","article-title":"The effect of diazepam on the metabolism of methadone by the liver of methadone-dependent rats","volume":"2","author":"Spaulding","year":"1974","journal-title":"Drug Metab. Disposition"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0250","doi-asserted-by":"crossref","first-page":"107677","DOI":"10.1016\/j.neuropharm.2019.107677","article-title":"Interactions of benzodiazepines with heroin: respiratory depression, temperature effects, and behavior","volume":"158","author":"Afzal","year":"2019","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.jpsychores.2020.110153_bb0255","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1360-0443.2009.02570.x","article-title":"Mortality among opiate users: opioid maintenance therapy, age and causes of death","volume":"104","author":"Clausen","year":"2009","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jpsychores.2020.110153_bb0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5055\/jom.2013.0156","article-title":"Codeine-associated pediatric deaths despite using recommended dosing guidelines: three case reports","volume":"9","author":"Friedrichsdorf","year":"2013","journal-title":"J. Opioid Manag."},{"issue":"4","key":"10.1016\/j.jpsychores.2020.110153_bb0265","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1542\/peds.106.4.633","article-title":"Adverse sedation events in pediatrics: analysis of medications used for sedation","volume":"106","author":"Cote","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0270","series-title":"Health at a Glance 2017: OECD Indicators","author":"OECD","year":"2017"},{"issue":"10","key":"10.1016\/j.jpsychores.2020.110153_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7100354","article-title":"Addressing opioid-related chemical coping in long-term opioid therapy for chronic noncancer pain: a Multicenter, observational, cross-sectional study","volume":"7","author":"Castaneda","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpsychores.2020.110153_bb0280","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jad.2015.08.050","article-title":"Characteristics of methods of suicide attempts in Korea: Korea National Suicide Survey","volume":"188","author":"Kim","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.jpsychores.2020.110153_bb0285","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1047-2797(97)00126-9","article-title":"Risk of suicide attempts after benzodiazepine and\/or antidepressant use","volume":"7","author":"Neutel","year":"1997","journal-title":"Ann. Epidemiol."},{"issue":"6","key":"10.1016\/j.jpsychores.2020.110153_bb0290","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1176\/appi.ajp.160.6.1041","article-title":"Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability","volume":"160","author":"Chambers","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychores.2020.110153_bb0295","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.addbeh.2008.10.021","article-title":"Early-onset drug use and risk for drug dependence problems","volume":"34","author":"Chen","year":"2009","journal-title":"Addict. Behav."},{"issue":"1\u20132","key":"10.1016\/j.jpsychores.2020.110153_bb0300","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addbeh.2010.09.003","article-title":"Psychotropic medication history of inpatient adolescents--is there a rationale for benzodiazepine prescription?","volume":"36","author":"Ilomaki","year":"2011","journal-title":"Addict. Behav."},{"issue":"1","key":"10.1016\/j.jpsychores.2020.110153_bb0305","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/02791072.2016.1269978","article-title":"Benzodiazepine dependence among young adult participants in the Club scene who use drugs","volume":"49","author":"Kurtz","year":"2017","journal-title":"J. Psychoactive Drugs"},{"issue":"8","key":"10.1016\/j.jpsychores.2020.110153_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134550","article-title":"Sex differences in dose escalation and overdose death during chronic opioid therapy: a population-based cohort study","volume":"10","author":"Kaplovitch","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jpsychores.2020.110153_bb0315","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/ADM.0000000000000086","article-title":"Sex differences among opioid-abusing patients with chronic pain in a clinical trial","volume":"9","author":"Manubay","year":"2015","journal-title":"J. Addict. Med."},{"issue":"2","key":"10.1016\/j.jpsychores.2020.110153_bb0320","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1213\/ANE.0000000000000792","article-title":"Predictors of delayed postoperative respiratory depression assessed from naloxone administration","volume":"121","author":"Weingarten","year":"2015","journal-title":"Anesth. Analg."},{"issue":"1","key":"10.1016\/j.jpsychores.2020.110153_bb0325","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ACO.0000000000000541","article-title":"Risk factors for opioid-induced respiratory depression and failure to rescue: a review","volume":"31","author":"Gupta","year":"2018","journal-title":"Curr. Opin. Anaesthesiol."},{"issue":"3","key":"10.1016\/j.jpsychores.2020.110153_bb0330","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jclinane.2010.09.003","article-title":"Life-threatening critical respiratory events: a retrospective study of postoperative patients found unresponsive during analgesic therapy","volume":"23","author":"Ramachandran","year":"2011","journal-title":"J. Clin. Anesth."},{"issue":"11","key":"10.1016\/j.jpsychores.2020.110153_bb0335","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/aje\/kwz169","article-title":"Association between transient opioid use and short-term respiratory exacerbation among adults with chronic obstructive pulmonary disease: a case-crossover study","volume":"188","author":"Rong","year":"2019","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.jpsychores.2020.110153_bb0340","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2019-000483","article-title":"Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease","volume":"7","author":"Le","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jpsychores.2020.110153_bb0345","series-title":"Optimization of Medication Teaching in Bunup(Separation of Drug Prescribing and Dispensing) System (Korean)","author":"Shin","year":"2002"}],"container-title":["Journal of Psychosomatic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399919309821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399919309821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:45:44Z","timestamp":1758368744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022399919309821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":69,"alternative-id":["S0022399919309821"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychores.2020.110153","relation":{},"ISSN":["0022-3999"],"issn-type":[{"value":"0022-3999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between opioid analgesic plus benzodiazepine use and death: A case-crossover study","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychosomatic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychores.2020.110153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110153"}}